Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Monitoring Cross-Contamination in Gel Manufacturing – V 2.0

Posted on By

Gel Manufacturing: SOP for Monitoring Cross-Contamination in Gel Manufacturing – V 2.0

Standard Operating Procedure for Monitoring Cross-Contamination in Gel Manufacturing

Department Gel Manufacturing
SOP No. SOP/GM/198/2025
Supersedes SOP/GM/198/2022
Page No. Page 1 of 8
Issue Date 10/06/2025
Effective Date 12/06/2025
Review Date 10/06/2027

1. Purpose

To define the procedure for monitoring and preventing cross-contamination in gel manufacturing operations, ensuring the integrity and safety of products.

2. Scope

This SOP applies to all gel manufacturing areas, including material handling, processing, equipment usage, and personnel movement within the facility.

3. Responsibilities

  • QA Department: Monitor compliance, review reports, and investigate any deviations.
  • Production Department: Implement preventive measures and ensure adherence to the procedure.
  • Engineering Department: Ensure facility design and HVAC systems support contamination control.

4. Accountability

The Head – Quality Assurance is accountable for ensuring effective implementation of this SOP.

See also  Gel Manufacturing: SOP for Manufacturing Gels with pH-Sensitive Drug Release - V 2.0

5. Procedure

5.1 Identification of Cross-Contamination Risks

  1. Perform
risk assessments for all manufacturing activities including equipment sharing, cleaning practices, and personnel flow.
  • Identify potential sources: raw materials, intermediates, product residues, environmental contaminants, and cleaning agents.
  • 5.2 Preventive Measures

    1. Ensure dedicated equipment or perform validated cleaning between product batches.
    2. Use color-coded tools and accessories for different production stages or products.
    3. Maintain physical segregation or use validated cleaning methods if equipment is shared.
    4. Implement airlocks and pressure differentials to control airborne contamination.

    5.3 Monitoring Mechanism

    1. Routine environmental monitoring through settle plates, swabs, and air samplers.
    2. Visual inspections during and after cleaning.
    3. Verification of cleaning effectiveness using swab tests and rinse samples.
    4. Batch-to-batch cross-contamination checks through analytical testing of swabs/rinse.

    5.4 Documentation and Reporting

    1. Record all monitoring data in the Cross-Contamination Monitoring Log (Annexure-1).
    2. Document inspection findings, deviations, and corrective actions in relevant formats (Annexure-2 and 3).

    5.5 Training and Awareness

    1. Conduct periodic training for personnel on contamination risks and control practices.
    2. Use case studies and past incidents as training material to improve awareness.

    5.6 Investigations and Corrective Actions

    1. Initiate deviation report if any instance of cross-contamination is suspected or detected.
    2. Conduct root cause analysis and implement CAPA (Corrective and Preventive Action).
    3. Review process design or layout if recurring contamination is observed.

    6. Abbreviations

    • CAPA: Corrective and Preventive Action
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure

    7. Documents

    1. Cross-Contamination Monitoring Log – Annexure-1
    2. Cleaning Verification Checklist – Annexure-2
    3. Cross-Contamination Deviation Form – Annexure-3
    4. Training Attendance Sheet – Annexure-4
    5. CAPA Implementation Record – Annexure-5

    8. References

    • WHO TRS 986 Annex 2: GMP for Pharmaceutical Products
    • EU GMP Guidelines – Chapter 5: Production
    • ICH Q9: Quality Risk Management

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation Jr. Production Chemist QA Executive Head – Manufacturing
    Department Gel Manufacturing Quality Assurance Manufacturing

    11. Annexures

    Annexure-1: Cross-Contamination Monitoring Log

    Date Area Sampling Type Result Remarks

    Annexure-2: Cleaning Verification Checklist

    Equipment ID Product Cleaned Cleaning Method Verified By Remarks

    Annexure-3: Cross-Contamination Deviation Form

    Deviation ID Description Detected By Corrective Action Approved By

    Annexure-4: Training Attendance Sheet

    Date Employee Name Department Trainer Signature

    Annexure-5: CAPA Implementation Record

    CAPA ID Description Implemented By Verification Date Status

    Revision History

    Revision Date Revision No. Change Description Reason Approved By
    02/03/2022 1.0 Initial issue New SOP QA Head
    10/06/2025 2.0 Added CAPA tracking and updated monitoring logs Process improvement QA Head
    See also  Gel Manufacturing: SOP for Labeling Machines for Gel Packaging - V 2.0
    Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

    Post navigation

    Previous Post: Inconsistent SOP Integration Across Sites: A Risk to Multi-Site GMP Compliance
    Next Post: Reviewing SOP Execution Logs Before Regulatory Audits

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version